Bazedoxifene appears to stop growth of breast cancer cells, including those in treatment-resistant tumors
FDA Highlights by Bruce Sylvester – Bazedoxifene, approved in Europe to treat osteoporosis, appears to stop the growth of breast cancer cells, even in therapy-resistant tumors, researchers from… read more.